Cargando…
Sarcopenia is associated with osteopenia and impaired quality of life in children with genetic intrahepatic cholestatic liver disease
BACKGROUND: Sarcopenia occurs in pediatric chronic liver disease, although the prevalence and contributing factors in genetic intrahepatic cholestasis are not well-described. The objective of this study was to measure muscle mass in school-aged children with genetic intrahepatic cholestasis and asse...
Autores principales: | Boster, Julia M., Goodrich, Nathan P., Spino, Cathie, Loomes, Kathleen M., Alonso, Estella M., Kamath, Binita M., Sokol, Ronald J., Karpen, Saul, Miethke, Alexander, Shneider, Benjamin L., Molleston, Jean P., Kohli, Rohit, Horslen, Simon P., Rosenthal, Philip, Valentino, Pamela L., Teckman, Jeffrey H., Hangartner, Thomas N., Sundaram, Shikha S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10617863/ https://www.ncbi.nlm.nih.gov/pubmed/37902507 http://dx.doi.org/10.1097/HC9.0000000000000293 |
Ejemplares similares
-
Use of funded multicenter prospective longitudinal databases to inform clinical trials in rare diseases—Examination of cholestatic liver disease in Alagille syndrome
por: Shneider, Benjamin L., et al.
Publicado: (2022) -
Nonfasted Liver Stiffness Correlates with Liver Disease Parameters and Portal Hypertension in Pediatric Cholestatic Liver Disease
por: Shneider, Benjamin L., et al.
Publicado: (2020) -
Unraveling the Relationship Between Itching, Scratch Scales, and Biomarkers in Children With Alagille Syndrome
por: Kamath, Binita M., et al.
Publicado: (2020) -
Impact of long‐term administration of maralixibat on children with cholestasis secondary to Alagille syndrome
por: Shneider, Benjamin L., et al.
Publicado: (2022) -
Placebo‐Controlled Randomized Trial of an Intestinal Bile Salt Transport Inhibitor for Pruritus in Alagille Syndrome
por: Shneider, Benjamin L., et al.
Publicado: (2018)